The biopharmaceutical industry has 282 drugs undergoing clinical development or FDA evaluation for conditions affecting the pediatric population, the Pharmaceutical Research and Manufacturers of America reported. The lineup includes therapeutic candidates for cancer, infectious diseases, genetic diseases and neurological illnesses. Researchers are also evaluating many existing drugs for use in children.

Full Story:
PharmaTimes (U.K.)

Related Summaries